Tag: Vesper Medical
Duo venous stent system shows 90.2% primary patency at 12 months,...
The Duo venous stent system (Vesper Medical/Philips) showed a 98.7% freedom from major adverse events (MAEs) at 30 days and 90.2% primary patency at...
Philips acquires Vesper Medical
Royal Philips today announced that it has signed an agreement to acquire Vesper Medical, a US-based medical technology company that develops minimally-invasive peripheral vascular...
